205 related articles for article (PubMed ID: 24130830)
1. HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome.
Näsman A; Andersson E; Marklund L; Tertipis N; Hammarstedt-Nordenvall L; Attner P; Nyberg T; Masucci GV; Munck-Wikland E; Ramqvist T; Dalianis T
PLoS One; 2013; 8(10):e77025. PubMed ID: 24130830
[TBL] [Abstract][Full Text] [Related]
2. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome.
Sivars L; Näsman A; Tertipis N; Vlastos A; Ramqvist T; Dalianis T; Munck-Wikland E; Nordemar S
Cancer Med; 2014 Apr; 3(2):376-84. PubMed ID: 24510528
[TBL] [Abstract][Full Text] [Related]
5. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
7. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
Berdugo J; Rooper LM; Chiosea SI
Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
[TBL] [Abstract][Full Text] [Related]
8. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
Huang H; Zhang B; Chen W; Zou SM; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
[TBL] [Abstract][Full Text] [Related]
11. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
12. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
Shi W; Kato H; Perez-Ordonez B; Pintilie M; Huang S; Hui A; O'Sullivan B; Waldron J; Cummings B; Kim J; Ringash J; Dawson LA; Gullane P; Siu L; Gillison M; Liu FF
J Clin Oncol; 2009 Dec; 27(36):6213-21. PubMed ID: 19884544
[TBL] [Abstract][Full Text] [Related]
13. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
[TBL] [Abstract][Full Text] [Related]
14. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
[TBL] [Abstract][Full Text] [Related]
15. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
16. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
[TBL] [Abstract][Full Text] [Related]
20. Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx.
Junor E; Kerr G; Oniscu A; Campbell S; Kouzeli I; Gourley C; Cuschieri K
Br J Cancer; 2012 Jan; 106(2):358-65. PubMed ID: 22146523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
